Clinicopathological implications of leptin and leptin receptor expression in papillary thyroid cancer

Zhang,Guo-An; Hou,Sen; Han,Sha; Zhou,Jian; Wang,Xu; Cui,Wen

doi:10.3892/ol.2013.1125

Clinicopathological implications of leptin and leptin receptor expression in papillary thyroid cancer

Authors:
- Guo-An Zhang
- Sen Hou
- Sha Han
- Jian Zhou
- Xu Wang
- Wen Cui
View Affiliations

Affiliations: Department of Pathology, Jining Medical University, Jining, Shandong 272067, P.R. China, Life Science Experimental Center, Jining Medical University, Jining, Shandong 272067, P.R. China, Center of Forensic Science, Jining Medical University, Jining, Shandong 272067, P.R. China
Published online on: January 10, 2013 https://doi.org/10.3892/ol.2013.1125
Pages: 797-800

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The role of leptin and its receptors (OBRs) in the pathogenesis of various primary human malignancies has been demonstrated. However, their expression and clinicopathological significance in papillary thyroid cancer (PTC) is not fully understood. In this study, we examined the expression of leptin and OBRs in 76 PTC samples using immunohistochemistry, and their associations with clinicopathological parameters were evaluated. The expression of OBRs was observed in the tumor cell membrane and/or cytoplasm, with a positive rate of 73.7% (56/76), while leptin was expressed in the tumor cell cytoplasm in 55 of 76 cases (72.4%). The expression of either protein was associated with greater tumor size (P=0.016 for leptin and P=0.002 for OBRs). In addition, the expression levels of leptin and OBRs were associated with each other. Neither leptin nor OBR expression levels were associated with other parameters, including age, body weight, postmenopausal state, multifocality and lymph node metastasis. These data suggest that the expression of leptin and/or OBRs in PTC is associated with tumor size and may be a potential target in PTC.

View Figures

View References

1	Simard EP, Ward EM, Siegel R and Jemal A: Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. Jan 4–2012.(Epub ahead of print).
2	Chen AY, Jemal A and Ward EM: Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer. 115:3801–3807. 2009.
3	Olaleye O, Ekrikpo U, Moorthy R, et al: Increasing incidence of differentiated thyroid cancer in South East England: 1987–2006. Eur Arch Otorhinolaryngol. 268:899–906. 2011.PubMed/NCBI
4	Capezzone M, Morabito E, Bellitti P, Giannasio P, De Sanctis D and Bruno R: Increasing incidence of thyroid cancer in Basilicata: an Italian study. J Endocrinol Invest. 30:507–512. 2007. View Article : Google Scholar : PubMed/NCBI
5	Smailyte G, Miseikyte-Kaubriene E and Kurtinaitis J: Increasing thyroid cancer incidence in Lithuania in 1978–2003. BMC Cancer. 6:2842006.PubMed/NCBI
6	Liu S, Semenciw R, Ugnat AM and Mao Y: Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects. Br J Cancer. 85:1335–1339. 2001.
7	Xiang J, Wu Y, Li DS, et al: New clinical features of thyroid cancer in eastern China. J Visc Surg. 147:e53–e56. 2010. View Article : Google Scholar : PubMed/NCBI
8	Finucane MM, Stevens GA, Cowan MJ, et al: National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 377:557–567. 2011.
9	Wang Y, Mi J, Shan XY, Wang QJ and Ge KY: Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond). 31:177–188. 2007. View Article : Google Scholar : PubMed/NCBI
10	Chen CM: Overview of obesity in Mainland China. Obes Rev. 9(Suppl 1): 14–21. 2008. View Article : Google Scholar
11	Khandekar MJ, Cohen P and Spiegelman BM: Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 11:886–895. 2011. View Article : Google Scholar : PubMed/NCBI
12	Renehan AG, Tyson M, Egger M, Heller RF and Zwahlen M: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 371:569–578. 2008. View Article : Google Scholar : PubMed/NCBI
13	Roberts DL, Dive C and Renehan AG: Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med. 61:301–316. 2010. View Article : Google Scholar : PubMed/NCBI
14	Zhang Y, Proenca R, Maffei M, Barone M, Leopold L and Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
15	Sweeney G: Leptin signalling. Cell Signal. 14:655–663. 2002. View Article : Google Scholar : PubMed/NCBI
16	Garofalo C and Surmacz E: Leptin and cancer. J Cell Physiol. 207:12–22. 2006. View Article : Google Scholar
17	Riolfi M, Ferla R, Del Valle L, et al: Leptin and its receptor are overexpressed in brain tumors and correlate with the degree of malignancy. Brain Pathol. 20:481–489. 2010. View Article : Google Scholar : PubMed/NCBI
18	Ishikawa M, Kitayama J and Nagawa H: Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res. 10:4325–4331. 2004. View Article : Google Scholar : PubMed/NCBI
19	Hoon Kim J, Lee SY, Myung SC, Kim YS, Kim TH and Kim MK: Clinical significance of the leptin and leptin receptor expressions in prostate tissues. Asian J Androl. 10:923–928. 2008.PubMed/NCBI
20	Uddin S, Bu R, Ahmed M, et al: Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer. Mol Cancer. 8:742009. View Article : Google Scholar : PubMed/NCBI
21	Koda M, Sulkowska M, Kanczuga-Koda L, Surmacz E and Sulkowski S: Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol. 60:902–906. 2007. View Article : Google Scholar : PubMed/NCBI
22	Liu H, Wan D, Pan Z, et al: Expression and biological significance of leptin, leptin receptor, VEGF, and CD34 in colorectal carcinoma. Cell Biochem Biophys. 60:241–244. 2011. View Article : Google Scholar : PubMed/NCBI
23	Uddin S, Bavi P, Siraj AK, et al: Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma. Endocr Relat Cancer. 17:191–202. 2010. View Article : Google Scholar : PubMed/NCBI
24	Cheng SP, Chi CW, Tzen CY, et al: Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma. Surgery. 147:847–853. 2010. View Article : Google Scholar : PubMed/NCBI
25	Koda M, Sulkowska M, Wincewicz A, et al: Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer. Ann NY Acad Sci. 1095:90–98. 2007. View Article : Google Scholar : PubMed/NCBI
26	Koda M, Sulkowska M, Kanczuga-Koda L, et al: Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1 alpha in human colorectal cancer. Ann Oncol. 18(Suppl 6): vi116–119. 2007. View Article : Google Scholar : PubMed/NCBI
27	Koda M, Kanczuga-Koda L, Sulkowska M, Surmacz E and Sulkowski S: Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and meta-static breast cancer: effects of preoperative chemotherapy. BMC Cancer. 10:3202010. View Article : Google Scholar
28	Garofalo C, Koda M, Cascio S, et al: Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res. 12:1447–1453. 2006. View Article : Google Scholar : PubMed/NCBI
29	Chen C, Chang YC, Liu CL, Chang KJ and Guo IC: Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Breast Cancer Res Treat. 98:121–132. 2006. View Article : Google Scholar : PubMed/NCBI
30	Cheng SP, Liu CL, Hsu YC, Chang YC, Huang SY and Lee JJ: Regulation of leptin receptor expression in human papillary thyroid cancer cells. Biomed Pharmacother. 66:469–473. 2012. View Article : Google Scholar : PubMed/NCBI
31	Cheng SP, Yin PH, Chang YC, Lee CH, Huang SY and Chi CW: Differential roles of leptin in regulating cell migration in thyroid cancer cells. Oncol Rep. 23:1721–1727. 2010.PubMed/NCBI
32	Cheng SP, Yin PH, Hsu YC, et al: Leptin enhances migration of human papillary thyroid cancer cells through the PI3K/AKT and MEK/ERK signaling pathways. Oncol Rep. 26:1265–1271. 2011.PubMed/NCBI